A recent bioinformatics study which analyzed major datasets including The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and Gene Expression Profiling Interactive Analysis (GEPIA) demonstrated poor relapse-free survival and overall survival in breast cancer with higher level of GLUT1 expression [31]. Here, SLC2A1 is linked to breast cancer.